<p>Lake Street 的分析師 Chad Messer 今天對 OS Therapies Incorporated 維持了買入評級，並設定了 17.00 美元的目標價。</p>
<h3>享受 TipRanks Premium 50% 折扣，放心投資</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，幫助您做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，使您的投資組合始終處於最大潛力的狀態</li>
</ul>
<p>Messer 關注醫療保健行業，重點關注 Coya Therapeutics, Inc.、OS Therapies Incorporated 和 Oncolytics Biotech 等股票。根據 TipRanks 的數據，Messer 推薦股票的平均回報為 -0.6%，成功率為 37.09%。</p>
<p>OS Therapies Incorporated 的分析師共識為適度買入，目標價共識為 11.50 美元。</p>

OSTX

<p>Lake Street 分析師 Chad Messer 對 OS Therapies Incorporated 維持買入評級，設定目標價為 17.00 美元。該分析師的平均回報為 -0.6%，成功率為 37.09%。OS Therapies 的共識評級為適度買入，目標價為 11.50 美元</p>

<p>Lake Street analyst Chad Messer maintained a Buy rating on OS Therapies Incorporated today and set a price target of $17.00.</p>
<div class="lb-trans"><p>Lake Street 的分析師 Chad Messer 今天對 OS Therapies Incorporated 維持了買入評級，並設定了 17.00 美元的目標價。</p>
</div><h3>Claim 50% Off TipRanks Premium and Invest with Confidence</h3>
<div class="lb-trans"><h3>享受 TipRanks Premium 50% 折扣，放心投資</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，幫助您做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，使您的投資組合始終處於最大潛力的狀態</li>
</ul>
</div><p>Messer covers the Healthcare sector, focusing on stocks such as Coya Therapeutics, Inc., OS Therapies Incorporated, and Oncolytics Biotech. According to TipRanks, Messer has an average return of -0.6% and a 37.09% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Messer 關注醫療保健行業，重點關注 Coya Therapeutics, Inc.、OS Therapies Incorporated 和 Oncolytics Biotech 等股票。根據 TipRanks 的數據，Messer 推薦股票的平均回報為 -0.6%，成功率為 37.09%。</p>
</div><p>OS Therapies Incorporated has an analyst consensus of Moderate Buy, with a price target consensus of $11.50.</p>
<div class="lb-trans"><p>OS Therapies Incorporated 的分析師共識為適度買入，目標價共識為 11.50 美元。</p>
</div>

Lake Street 維持對 OS Therapies Incorporated（OSTX）的買入評級